300357.SZ
我武生物
SZSE · Healthcare · C 制造业 · CN
CNY 23.26
−5.64%Margins
Gross margin
95.3%
EBITDA margin
45.1%
EBIT margin
44.8%
Net margin
39.2%
FCF margin
27.5%
15.5%
Return on equity
14.5%
Return on assets
17.7%
Return on invested capital
0.37x
Asset turnover
CNY 392.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026